Twist Bioscience
TWST
103.32
-8.30
-7.44%
Twist Bioscience
US · TWST
#1258 by market cap
Listed 2018
103.32
-8.30
-7.44%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:52
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Evercore moved from Buy to Hold on 2026-07-06.
Analyst consensus 8 analysts
Buy
Avg price target 130.25 +26.1%
Price target rangecurrent 103.32
Low45.00
Avg130.25
High175.00
Buy 75%
Hold 13%
Sell 13%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-16 | Leerink Partners | -- | Buy | 175.00 |
| 2026-11-13 | TD Cowen | -- | Buy | 137.00 |
| 2026-11-13 | CCORF | -- | Buy | 150.00 |
| 2026-11-13 | UBS | -- | Hold | 120.00 |
| 2026-11-13 | Baird | -- | Buy | 135.00 |
| 2026-11-13 | Leerink Partners | -- | Buy | 175.00 |
| 2026-11-13 | Barclays | -- | Buy | 130.00 |
| 2026-11-12 | CCORF | -- | Buy | 150.00 |
| 2026-11-12 | Guggenheim | -- | Buy | 150.00 |
| 2026-10-13 | TD Cowen | -- | Buy | 190.00 |
| 2026-10-12 | CCORF | -- | Buy | 205.00 |
| 2026-10-07 | Barclays | -- | Buy | 215.00 |
| 2026-10-01 | Guggenheim | -- | Buy | 212.00 |
| 2026-09-29 | Leerink Partners | -- | Buy | 190.00 |
| 2026-09-18 | BWS Financial | -- | Sell | 45.00 |
| 2026-09-17 | Leerink Partners | -- | Buy | 160.00 |
| 2026-09-09 | BWS Financial | -- | Sell | 45.00 |
| 2026-08-05 | Piper Sandler | -- | Buy | 115.00 |
| 2026-08-04 | Baird | -- | Buy | 115.00 |
| 2026-08-03 | TD Cowen | -- | Buy | 115.00 |
| 2026-08-03 | CCORF | -- | Buy | 120.00 |
| 2026-08-03 | William Blair | -- | Buy | -- |
| 2026-08-03 | Barclays | -- | Buy | 112.00 |
| 2026-07-17 | Leerink Partners | -- | Buy | 110.00 |
| 2026-07-16 | Leerink Partners | -- | Buy | 110.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-06 | Evercore | Buy → Hold | 102.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q4 | 2026-11-12 | -- | ±16.90% | -6.83% (in line) |
| 2026/Q3 | 2026-08-03 | -- | ±19.17% | +10.39% (in line) |
| 2026/Q2 | 2026-05-04 | -- | ±15.27% | -6.97% (in line) |
| 2026/Q1 | 2026-02-02 | -- | ±17.32% | +13.98% (in line) |
| 2025/Q4 | 2025-11-14 | -- | ±18.25% | -10.13% (in line) |
| 2025/Q3 | 2025-08-04 | -- | ±22.88% | -10.30% (in line) |
| 2025/Q2 | 2025-05-05 | -- | ±15.16% | -8.44% (in line) |
| 2025/Q1 | 2025-02-03 | -- | ±17.15% | +0.73% (in line) |
| 2024/Q4 | 2024-11-18 | -- | ±23.08% | +12.31% (in line) |
| 2024/Q3 | 2024-08-02 | -- | ±22.44% | -19.00% (in line) |
| 2024/Q2 | 2024-05-02 | After close | ±17.01% | +28.74% (beat) |
| 2024/Q1 | 2024-02-02 | -- | ±19.08% | +10.01% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:52:04 · For reference only, not investment advice and not tailored to your situation.
Twist Bioscience discussion 0 comments